Humira 40 mg/0.8 mL for Subcutaneous Injection - Drug Use Investigation (All Patient Investigation) for Rheumatoid Arthritis
Phase of Trial: Phase IV
Latest Information Update: 27 Aug 2012
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 06 Aug 2012 Actual patient number changed from 7891 to 7972 as reported by ClinicalTrials.gov.
- 21 Jul 2011 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
- 21 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.